Filling in the Blind Spot: Integrating Charles Bonnet Syndrome Screening in Ophthalmology

Philip John Borsellino, Savannah Schauer,* Axel Rivas,* Karl Aharonian, Thomas A Vida Department of Medical Education, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, USA*These authors contributed equally to this workCorrespondence: Thomas A Vida, Kirk Kerkorian School of Medicine at UNLV, 625 Shadow Lane, Las Vegas, NV, 89106, Email [email protected]: Charles Bonnet Syndrome (CBS) is an underdiagnosed condition affecting patients with significant vision loss who experience complex visual hallucinations while maintaining cognitive insight. This scoping review aims to synthesize existing literature on CBS prevalence, risk factors, and screening practices, and to propose a standardized, clinically implementable screening workflow for ophthalmologists.Patients and Methods: We conducted a structured literature search across four databases (PubMed, Embase, Web of Science, Scopus) using keywords related to CBS, visual impairment, screening, and diagnosis. Inclusion criteria encompassed peer-reviewed studies involving patients with vision loss that reported the use of screening tools, diagnostic criteria, or clinical assessments of CBS. Excluded were case reports with fewer than five patients, articles lacking full text or peer review, and those focused primarily on psychiatric or neurologic hallucinations. We identified 1,582 articles, with 89 studies meeting the final inclusion criteria.Results: CBS prevalence ranged from 2% to 30%, depending on the underlying ocular condition and screening method used. Age-related macular degeneration showed the highest association. Few studies utilized validated screening tools though the QR-SCB and NEVHI instruments demonstrated clinical utility. Barriers to diagnosis included patient reluctance to report symptoms and clinician unfamiliarity. We developed a pragmatic clinical model incorporating risk stratification, direct questioning, validated tools, and functional assessment to improve detection in ophthalmology clinics.Conclusion: CBS remains underdiagnosed despite its significant psychosocial burden. A structured screening approach may increase diagnostic accuracy and support timely intervention. The proposed model offers ophthalmologists a practical pathway to integrate CBS assessment into routine care.Keywords: visual perception disorders, low vision, hallucinations, clinical assessment tools, elderly patients, diagnostic algorithms

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-10-01
Primary Topic
Wood Treatment and Properties
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Filling in the Blind Spot: Integrating Charles Bonnet Syndrome Screening in Ophthalmology

SHILAP Revista de lepidopterología
Wood Treatment and Properties
article

Filling in the Blind Spot: Integrating Charles Bonnet Syndrome Screening in Ophthalmology

article en

Abstract

Philip John Borsellino, Savannah Schauer,* Axel Rivas,* Karl Aharonian, Thomas A Vida Department of Medical Education, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, USA*These authors contributed equally to this workCorrespondence: Thomas A Vida, Kirk Kerkorian School of Medicine at UNLV, 625 Shadow Lane, Las Vegas, NV, 89106, Email [email protected]: Charles Bonnet Syndrome (CBS) is an underdiagnosed condition affecting patients with significant vision loss who experience complex visual hallucinations while maintaining cognitive insight. This scoping review aims to synthesize existing literature on CBS prevalence, risk factors, and screening practices, and to propose a standardized, clinically implementable screening workflow for ophthalmologists.Patients and Methods: We conducted a structured literature search across four databases (PubMed, Embase, Web of Science, Scopus) using keywords related to CBS, visual impairment, screening, and diagnosis. Inclusion criteria encompassed peer-reviewed studies involving patients with vision loss that reported the use of screening tools, diagnostic criteria, or clinical assessments of CBS. Excluded were case reports with fewer than five patients, articles lacking full text or peer review, and those focused primarily on psychiatric or neurologic hallucinations. We identified 1,582 articles, with 89 studies meeting the final inclusion criteria.Results: CBS prevalence ranged from 2% to 30%, depending on the underlying ocular condition and screening method used. Age-related macular degeneration showed the highest association. Few studies utilized validated screening tools though the QR-SCB and NEVHI instruments demonstrated clinical utility. Barriers to diagnosis included patient reluctance to report symptoms and clinician unfamiliarity. We developed a pragmatic clinical model incorporating risk stratification, direct questioning, validated tools, and functional assessment to improve detection in ophthalmology clinics.Conclusion: CBS remains underdiagnosed despite its significant psychosocial burden. A structured screening approach may increase diagnostic accuracy and support timely intervention. The proposed model offers ophthalmologists a practical pathway to integrate CBS assessment into routine care.Keywords: visual perception disorders, low vision, hallucinations, clinical assessment tools, elderly patients, diagnostic algorithms

SHILAP Revista de lepidopterología
Ophthalmology Associates (United States) (US)
Quality Education
Openalex Percentile: Top 48%
Wood Treatment and Properties
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.